A team of experts with the University of Maryland School of Medicine recently presented ChatGPT with a set of questions relative to breast cancer screening recommendations to determine whether the program could reliably offer appropriate guidance.

A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.

Radiologists used an AI tool-building platform to create their model(s), which allows clinicians the opportunity to develop AI models without any prior training in data sciences or computer programming. 

Radiology AI vendor Bot Image may market its prostate software not only for diagnosing cancer when suspected but also for performing prostate screenings.

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.

AI clinical decision support was particularly popular among younger radiologists, experts wrote in Scientific Reports. 

Registered nurses, NPs and EMTs bolstered the quality of their scans with the help of deep learning-based guidance.

The generated report included indication, findings laid out numerically, TNM stage, impression and follow-up recommendations.